CY2015027I1 - Μεθοδος για τη βελτιωση της βιοδιαθεσιμοτητας της οσπεμιφενης - Google Patents

Μεθοδος για τη βελτιωση της βιοδιαθεσιμοτητας της οσπεμιφενης

Info

Publication number
CY2015027I1
CY2015027I1 CY2015027C CY2015027C CY2015027I1 CY 2015027 I1 CY2015027 I1 CY 2015027I1 CY 2015027 C CY2015027 C CY 2015027C CY 2015027 C CY2015027 C CY 2015027C CY 2015027 I1 CY2015027 I1 CY 2015027I1
Authority
CY
Cyprus
Prior art keywords
ospemifene
bioavailability
improving
Prior art date
Application number
CY2015027C
Other languages
English (en)
Other versions
CY2015027I2 (el
Original Assignee
Hormos Medical Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34837941&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY2015027(I1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Hormos Medical Ltd. filed Critical Hormos Medical Ltd.
Publication of CY2015027I1 publication Critical patent/CY2015027I1/el
Publication of CY2015027I2 publication Critical patent/CY2015027I2/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Mycology (AREA)
  • Polymers & Plastics (AREA)
  • Reproductive Health (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CY2015027C 2004-02-13 2015-07-08 Μεθοδος για τη βελτιωση της βιοδιαθεσιμοτητας της οσπεμιφενης CY2015027I2 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/777,211 US8236861B2 (en) 2004-02-13 2004-02-13 Method for enhancing the bioavailablity of ospemifene
PCT/FI2005/000018 WO2005077350A1 (en) 2004-02-13 2005-01-14 Method for enhancing the bioavailability of ospemifene

Publications (2)

Publication Number Publication Date
CY2015027I1 true CY2015027I1 (el) 2016-04-13
CY2015027I2 CY2015027I2 (el) 2016-04-13

Family

ID=34837941

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20081100456T CY1111014T1 (el) 2004-02-13 2008-04-24 Μεθοδος για τη βελτιωση της βιοδιαθεσιμοτητας της οσπεμιφενης
CY2015027C CY2015027I2 (el) 2004-02-13 2015-07-08 Μεθοδος για τη βελτιωση της βιοδιαθεσιμοτητας της οσπεμιφενης

Family Applications Before (1)

Application Number Title Priority Date Filing Date
CY20081100456T CY1111014T1 (el) 2004-02-13 2008-04-24 Μεθοδος για τη βελτιωση της βιοδιαθεσιμοτητας της οσπεμιφενης

Country Status (21)

Country Link
US (5) US8236861B2 (el)
EP (1) EP1713458B1 (el)
JP (2) JP5577011B2 (el)
CN (1) CN1925847A (el)
AT (1) ATE387910T1 (el)
AU (1) AU2005211958B2 (el)
BR (1) BRPI0507661A (el)
CA (1) CA2556089C (el)
CY (2) CY1111014T1 (el)
DE (1) DE602005005165T2 (el)
DK (1) DK1713458T5 (el)
ES (1) ES2302177T3 (el)
HU (1) HUS1500030I1 (el)
LT (1) LTC1713458I2 (el)
LU (1) LU92736I2 (el)
MX (1) MXPA06009274A (el)
NO (2) NO337656B1 (el)
PL (1) PL1713458T3 (el)
PT (1) PT1713458E (el)
RU (1) RU2385716C2 (el)
WO (1) WO2005077350A1 (el)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) * 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
DK2275098T3 (da) 2004-05-04 2012-08-20 Hormos Medical Ltd Hidtil ukendte orale formulationer af ospemifen
CA2628964A1 (en) * 2005-11-09 2007-09-07 Hormos Medical Ltd. Formulations of fispemifene
US8637706B2 (en) 2005-11-28 2014-01-28 Gtx, Inc. Nuclear receptor binding agents
US9409856B2 (en) 2005-11-28 2016-08-09 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
CN102702013B (zh) * 2005-11-28 2016-02-10 Gtx公司 核受体结合剂
US8546451B2 (en) 2005-11-28 2013-10-01 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US8158828B2 (en) * 2005-11-28 2012-04-17 Gtx, Inc. Nuclear receptor binding agents
ES2524002T3 (es) * 2007-02-14 2014-12-03 Forendo Pharma Ltd. Método para la preparación de derivados de trifenilbuteno con valor terapéutico
WO2008099060A2 (en) * 2007-02-14 2008-08-21 Hormos Medical Ltd Methods for the preparation of fispemifene from ospemifene
US9427418B2 (en) 2009-02-23 2016-08-30 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
US9624161B2 (en) 2009-02-23 2017-04-18 Gtx, Inc. Estrogen receptor ligands and methods of use thereof
JP6174156B2 (ja) 2012-10-19 2017-08-02 フェルミオン オサケ ユキチュア オスペミフェンの製造方法
CN103739456A (zh) * 2013-12-03 2014-04-23 镇江圣安医药有限公司 2-（对-（（z-4-氯-1,2-二苯基-1-丁烯基）苯氧基）乙醇的新型衍生物及其应用
GR1009542B (el) 2018-04-25 2019-06-07 Φαρματεν Α.Β.Ε.Ε. Καψουλα μαλακης γελης που περιλαμβανει εναν εκλεκτικο ρυθμιστη οιστρογονικων υποδοχεων
EP4279133A3 (en) 2018-05-11 2024-02-21 Xenon Pharmaceuticals Inc. Methods for enhancing the bioavailability and exposure of a voltage-gated potassium channel opener

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207437D0 (en) 1992-04-03 1992-05-20 Orion Yhtymae Oy Topical administration of toremifene and its metabolites
GB9418067D0 (en) 1994-09-07 1994-10-26 Orion Yhtymae Oy Triphenylethylenes for the prevention and treatment of osteoporosis
GB9604577D0 (en) 1996-03-04 1996-05-01 Orion Yhtymae Oy Serum cholesterol lowering agent
US6262098B1 (en) * 1998-08-07 2001-07-17 Chiron Corporation Estrogen receptor modulators
US6219674B1 (en) 1999-11-24 2001-04-17 Classen Immunotherapies, Inc. System for creating and managing proprietary product data
US6245819B1 (en) * 2000-07-21 2001-06-12 Hormos Medical Oy, Ltd. Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause
US6653639B1 (en) * 2000-10-17 2003-11-25 Nikon Corporation Chuck for mounting reticle to a reticle stage
CA2438816A1 (en) 2001-02-22 2002-09-06 Classen Immunotherapies, Inc. Improved algorithms and methods for products safety
FR2826811B1 (fr) 2001-06-27 2003-11-07 France Telecom Procede d'authentification cryptographique
ATE344025T1 (de) 2002-06-06 2006-11-15 Hormos Medical Ltd Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen
US8236861B2 (en) 2004-02-13 2012-08-07 Hormos Medical Corporation Method for enhancing the bioavailablity of ospemifene
US20050187302A1 (en) 2004-02-23 2005-08-25 Hormos Medical Corporation Method for treatment or prevention of osteoporosis in individuals with high bone turnover
US8642079B2 (en) 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
US8758821B2 (en) 2004-05-04 2014-06-24 Hormos Medical Ltd. Oral formulations of ospemifene
US20060293294A1 (en) 2004-09-03 2006-12-28 Hormos Medical Corporation Method for treatment or prevention of androgen deficiency

Also Published As

Publication number Publication date
US8236861B2 (en) 2012-08-07
RU2006132719A (ru) 2008-03-20
US20140303259A1 (en) 2014-10-09
US20120270952A1 (en) 2012-10-25
NO339190B1 (no) 2016-11-14
DK1713458T3 (da) 2008-07-07
RU2385716C2 (ru) 2010-04-10
BRPI0507661A (pt) 2007-07-17
JP6023119B2 (ja) 2016-11-09
NO20151603L (no) 2006-11-03
US9241915B2 (en) 2016-01-26
EP1713458B1 (en) 2008-03-05
CN1925847A (zh) 2007-03-07
JP2014141533A (ja) 2014-08-07
AU2005211958B2 (en) 2010-11-25
HUS1500030I1 (hu) 2015-08-28
DE602005005165T2 (de) 2009-04-30
LTC1713458I2 (lt) 2017-06-26
JP2007522190A (ja) 2007-08-09
CA2556089A1 (en) 2005-08-25
LTPA2015023I1 (lt) 2015-08-25
JP5577011B2 (ja) 2014-08-20
MXPA06009274A (es) 2007-04-16
CY1111014T1 (el) 2015-06-11
PL1713458T3 (pl) 2008-08-29
LU92736I2 (fr) 2015-08-10
AU2005211958A1 (en) 2005-08-25
US8772353B2 (en) 2014-07-08
CA2556089C (en) 2013-04-02
US9855224B2 (en) 2018-01-02
DE602005005165D1 (de) 2008-04-17
CY2015027I2 (el) 2016-04-13
US8470890B2 (en) 2013-06-25
WO2005077350A1 (en) 2005-08-25
PT1713458E (pt) 2008-05-07
NO337656B1 (no) 2016-05-23
US20160101065A1 (en) 2016-04-14
EP1713458A1 (en) 2006-10-25
ES2302177T3 (es) 2008-07-01
DK1713458T5 (da) 2008-09-29
NO20063960L (no) 2006-11-03
US20130324614A1 (en) 2013-12-05
ATE387910T1 (de) 2008-03-15
US20050182143A1 (en) 2005-08-18

Similar Documents

Publication Publication Date Title
CY2015027I1 (el) Μεθοδος για τη βελτιωση της βιοδιαθεσιμοτητας της οσπεμιφενης
PL1890546T3 (pl) Sposób poprawiania biodostępności kurkuminy
DK1828164T3 (da) Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider
DK1778668T3 (da) Fremgangsmåde til fremstilling af dihydropteridion
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
DE602005010597D1 (de) Bildaufzeichnungsverfahren
FI20055581A (fi) Erotusmenetelmä
DK1748077T3 (da) Fremgangsmåde til fremstilling af protein
DE602005023445D1 (de) Malverfahren
DE602005026520D1 (de) Malverfahren
DE602005021170D1 (de) Positionssuchverfahren
DK1831223T3 (da) Fremgangsmåde til fremstilling af L-biopterin
ITMI20042238A1 (it) Composti per fluoropolirterei
DK1794111T3 (da) Fremgangsmåde til fremstilling af cyclopentanon
DK1776099T3 (da) Fremgangsmåder til forbedring af biotilgængeligheden af en renininhibitor
ITMI20041143A1 (it) Polimorfi di fexofenadina e procedimento per la loro preparazione
DK1727792T3 (da) Fremgangsmåde til fremstilling af semicarbazoner
FI20050681A0 (fi) Paikoitusmenetelmä
DK1962960T3 (da) Fremgangsmåde til mikornisering
DK1786913T3 (da) Fremgangsmåde til fremstilling af diarylcycloalkylderivater
AT500374A3 (de) Verfahren zur bestimmung der produktionskosten
DE602005003567D1 (de) Ebenen-neuausrichtung nach einem epitaxieschritt
DK1833814T3 (da) Fremgangsmåde til fremstilling af substituerede 2-alkoxycarbonyl-3-aminothiophener
DK1735297T3 (da) Fremgangsmåde til fremstilling af benzoxathiepinderivater
ITMI20031591A1 (it) Metodo per fabbricare strutture di isolamento